Cargando…

The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are tauopathic parkinsonian syndromes, presently lacking disease-modifying treatments. Patients affected by these diseases suffer due to multidimensional deteriorations resulting in motor and cognitive impairment. Previously publis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alster, Piotr, Dunalska, Anna, Migda, Bartosz, Madetko, Natalia, Królicki, Leszek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606811/ https://www.ncbi.nlm.nih.gov/pubmed/34819913 http://dx.doi.org/10.3389/fneur.2021.767480

Ejemplares similares

The Role of Frontal Assessment Battery and Frontal Lobe Single-Photon Emission Computed Tomography in the Differential Diagnosis of Progressive Supranuclear Palsy Variants and Corticobasal Syndrome—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

Accumulation of Tau Protein, Metabolism and Perfusion—Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)
por: Alster, Piotr, et al.
Publicado: (2019)

The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
por: Alster, Piotr, et al.
Publicado: (2022)

The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System Atrophy
por: Kutyłowski, Michał, et al.
Publicado: (2023)

The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism Predominant
por: Madetko-Alster, Natalia, et al.
Publicado: (2022)

The Strengths and Obstacles in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA) Using Magnetic Resonance Imaging (MRI) and Perfusion Single Photon Emission Computed Tomography (SPECT)
por: Alster, Piotr, et al.
Publicado: (2022)

Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism
por: Krzosek, Patrycja, et al.
Publicado: (2022)

Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P)—A Clinical Challenge at the Boundaries of PSP and Parkinson's Disease (PD)
por: Alster, Piotr, et al.
Publicado: (2020)

The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes
por: Alster, Piotr, et al.
Publicado: (2022)

Caregiver strain in progressive supranuclear palsy and corticobasal syndromes
por: Kellermair, Lukas, et al.
Publicado: (2021)

Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)
por: Alster, Piotr, et al.
Publicado: (2020)

Is MRPI 2.0 More Useful than MRPI and M/P Ratio in Differential Diagnosis of PSP-P with Other Atypical Parkinsonisms?
por: Madetko, Natalia, et al.
Publicado: (2022)

Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy
por: Alster, Piotr, et al.
Publicado: (2019)

The Significance of Vascular Pathogenesis in the Examination of Corticobasal Syndrome
por: Dunalska, Anna, et al.
Publicado: (2021)

Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns
por: Madetko-Alster, Natalia, et al.
Publicado: (2023)

Language impairment in progressive supranuclear palsy and corticobasal syndrome
por: Peterson, Katie A., et al.
Publicado: (2019)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
por: Bluett, Brent, et al.
Publicado: (2021)

Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn)
por: Saito, Yuya, et al.
Publicado: (2022)

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
por: Lamb, Ruth, et al.
Publicado: (2016)

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Jabbari, Edwin, et al.
Publicado: (2020)

Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy
por: Tse, Nga Yan, et al.
Publicado: (2020)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Swallow, Diane M.A., et al.
Publicado: (2022)

Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant
por: Ling, H, et al.
Publicado: (2014)

Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Bharti, Komal, et al.
Publicado: (2017)

The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
por: Dodich, Alessandra, et al.
Publicado: (2019)

Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
por: Parmera, Jacy Bezerra, et al.
Publicado: (2022)

Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome
por: Whiteside, David J., et al.
Publicado: (2023)

Frontrunner in Translation: Progressive Supranuclear Palsy
por: Shoeibi, Ali, et al.
Publicado: (2019)

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020)

Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome
por: Jatale, Vinayak, et al.
Publicado: (2023)

Gene-Environment Interactions in Progressive Supranuclear Palsy
por: Litvan, Irene, et al.
Publicado: (2021)

Gait Analysis in Progressive Supranuclear Palsy Phenotypes
por: Picillo, Marina, et al.
Publicado: (2021)

Inflammation in multiple system atrophy
por: Leńska-Mieciek, Marta, et al.
Publicado: (2023)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020)

A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome
por: Chung, Eun Joo, et al.
Publicado: (2022)

Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ad1npgmb3sncc3l04v3ncs3jdp